Ledger.Open graph →
SEC Form D · filed December 21, 2011

NeuroTherapeutics Pharma, Inc

Offering
$47.5M
Sold
$12.0M
Exemption
—
Industry
Biotechnology
Location
CHICAGO, IL
Type
—

People & firms on this filing (16)

Stephen D. Collins, M.D., Ph.D · Chicago, ILExec · DirectorHolli A. Carlson · Chicago, ILExecCorey Goodman, Ph.D · Chicago, ILDirectorStephen D. Collins, M.D., Ph.D · CHICAGO, ILExec · DirectorThomas R. Beck, M.D · Chicago, ILDirectorHeath Lukatch, Ph.D · Chicago, ILDirectorRajeev Dadoo, Ph.D · Chicago, ILDirectorBrian B. Williams · Chicago, ILExecHolli A. Carlson · CHICAGO, ILExecLuke Evnin, Ph.D · Chicago, ILDirectorCorey Goodman, Ph.D · CHICAGO, ILDirectorJason Brown, Ph.D · CHICAGO, ILDirectorElaine V. Jones, Ph.D · CHICAGO, ILDirectorStephen P. Wanaski · CHICAGO, ILExecMichael Venuti, Ph.D · CHICAGO, ILExecTodd Verdoorn, Ph.D · CHICAGO, ILExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗